The Vericiguat in Vasospastic Angina (ViVA) trial: a double-blind placebo-controlled randomized cross-over study

28 August 2026 (08:15 - 08:33)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Clinical Science: management of coronary microvascular disease Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology